Tackling Histoplasmosis Infection in People Living with HIV from Latin America: From Diagnostic Strategy to Public Health Solutions

Histoplasmosis, caused by the thermally dimorphic fungus Histoplasma spp., is a disease with a broad clinical spectrum, presenting from asymptomatic/flu-like symptoms to progressive disseminated disease in people with immunosuppression. In recent years, the concept of histoplasmosis as a disease restricted to the American continent has changed, as now histoplasmosis is reported in many regions around the world. In Latin America, histoplasmosis represents a threat, especially in people with advanced HIV disease (AHD). Diagnosis of histoplasmosis in people living with HIV (PLHIV) is challenging due to the low index of suspicion of the disease, non-specificity of signs and symptoms, and limited access to specific laboratory testing, while the diagnostic delay is significantly associated with mortality. In the last decade, novel diagnostic tests have been developed for the rapid detection of histoplasmosis, such as commercial kits for antigen detection. Furthermore, advocacy groups were created that presented histoplasmosis as a public health problem, with emphasis on patients at risk of progressive disseminated disease. This review aims to discuss the impact of histoplasmosis associated with AHD in Latin America and the strategies employed to tackle histoplasmosis, from the implementation of laboratory testing to disease advocacy and public health interventions.

[1]  M. Xavier,et al.  Optimization of a commercial Histoplasma galactomannan EIA test in a population from an endemic area of histoplasmosis in southern Brazil , 2022, Mycoses.

[2]  F. Queiroz-Telles,et al.  Current situation of endemic mycosis in the Americas and the Caribbean: Proceedings of the first international meeting on endemic mycoses of the Americas (IMEMA) , 2022, Mycoses.

[3]  D. Stevens,et al.  Disseminated Histoplasmosis in Persons with HIV/AIDS, Southern Brazil, 2010–2019 , 2022, Emerging infectious diseases.

[4]  B. Bustamante,et al.  [Current status of progressive disseminated histoplasmosis in HIV infected patients in a third level hospital in Peru]. , 2022, Revista Iberoamericana de Micologia.

[5]  Beatriz Bustamante,et al.  Estado actual de la histoplasmosis diseminada progresiva en pacientes con infección por el VIH en un hospital de tercer nivel en Perú , 2022, Revista Iberoamericana de Micología.

[6]  D. Denning,et al.  Incidence of Histoplasmosis in a Cohort of People with HIV: From Estimations to Reality , 2021, Microorganisms.

[7]  T. Chiller,et al.  Validation and Concordance Analysis of a New Lateral Flow Assay for Detection of Histoplasma Antigen in Urine , 2021, Journal of fungi.

[8]  T. Chiller,et al.  Diagnosis of fungal opportunistic infections in people living with HIV from Guatemala and El Salvador , 2021, Mycoses.

[9]  Deving Arias Ramos,et al.  Closing gaps in histoplasmosis: clinical characteristics and factors associated with probable/histoplasmosis in HIV/AIDS hospitalized patients, a retrospective cross-sectional study in two tertiary centers in Pereira, Colombia , 2021, AIDS Research and Therapy.

[10]  Rachel L. Bailey,et al.  Occupational Histoplasmosis: Epidemiology and Prevention Measures , 2021, Journal of fungi.

[11]  M. Demar,et al.  Invasive Fungal Infections in Persons Living with HIV in an Amazonian Context: French Guiana, 2009–2019 , 2021, Journal of fungi.

[12]  T. Chiller,et al.  Implementation of rapid diagnostics assays for detection of histoplasmosis and cryptococcosis in central american people living with HIV , 2021, Mycoses.

[13]  J. P. Telles,et al.  Combining urine antigen and blood polymerase chain reaction for the diagnosis of disseminated histoplasmosis in hospitalized patients with advanced HIV disease. , 2021, Medical mycology.

[14]  D. Denning,et al.  A Rapid Screening Program for Histoplasmosis, Tuberculosis, and Cryptococcosis Reduces Mortality in HIV Patients from Guatemala , 2021, Journal of fungi.

[15]  Q. Bassat,et al.  High prevalence and mortality due to Histoplasma capsulatum in the Brazilian Amazon: An autopsy study , 2021, PLoS neglected tropical diseases.

[16]  G. Reyes-Terán,et al.  Diagnostic accuracy of antigen detection in urine and molecular assays testing in different clinical samples for the diagnosis of progressive disseminated histoplasmosis in patients living with HIV/AIDS: A prospective multicenter study in Mexico , 2021, PLoS neglected tropical diseases.

[17]  S. Lockhart,et al.  Endemic and Other Dimorphic Mycoses in The Americas , 2021, Journal of fungi.

[18]  Brendan R. Jackson,et al.  Health Care Providers' Testing Practices for Coccidioidomycosis and Histoplasmosis in Patients With Community-Acquired Pneumonia-United States, 2020. , 2021, Open forum infectious diseases.

[19]  Brendan R. Jackson,et al.  Symptoms in blastomycosis, coccidioidomycosis, and histoplasmosis versus other respiratory illnesses in commercially insured adult outpatients, United States, 2016-2017. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  Brendan R. Jackson,et al.  Public Awareness of Invasive Fungal Diseases — United States, 2019 , 2020, MMWR. Morbidity and mortality weekly report.

[21]  Mathieu Nacher,et al.  Disseminated Histoplasmosis in HIV-Infected Patients: A Description of 34 Years of Clinical and Therapeutic Practice , 2020, Journal of fungi.

[22]  D. Denning,et al.  Comparative performance of the laboratory assays used by a diagnostic laboratory hub for opportunistic infections in people living with HIV. , 2020, AIDS.

[23]  P. Garner,et al.  Guidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV , 2020 .

[24]  Brendan R. Jackson,et al.  Re-drawing the Maps for Endemic Mycoses , 2020, Mycopathologia.

[25]  T. Chiller,et al.  Evaluation of a Histoplasma antigen lateral flow assay for the rapid diagnosis of progressive disseminated histoplasmosis in Colombian patients with AIDS , 2020, Mycoses.

[26]  D. Denning,et al.  The Diagnostic Laboratory Hub: A New Health Care System Reveals the Incidence and Mortality of Tuberculosis, Histoplasmosis, and Cryptococcosis of PWH in Guatemala , 2019, Open forum infectious diseases.

[27]  J. Perfect,et al.  Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  T. Chiller,et al.  The Manaus Declaration: Current Situation of Histoplasmosis in the Americas, Report of the II Regional Meeting of the International Histoplasmosis Advocacy Group , 2019, Current Fungal Infection Reports.

[29]  Diego H. Cáceres,et al.  Diagnosis of Progressive Disseminated Histoplasmosis in Advanced HIV: A Meta-Analysis of Assay Analytical Performance , 2019, Journal of Fungi.

[30]  Audrey Valdes,et al.  Histoplasmosis and Tuberculosis Co-Occurrence in People with Advanced HIV , 2019, Journal of fungi.

[31]  B. Barker,et al.  Fantastic yeasts and where to find them: the hidden diversity of dimorphic fungal pathogens. , 2019, Current opinion in microbiology.

[32]  Mathieu Nacher,et al.  Accuracy of Buffy Coat in the Diagnosis of Disseminated Histoplasmosis in AIDS-Patients in an Endemic Area of Brazil , 2019, Journal of fungi.

[33]  Mathieu Nacher,et al.  The Fight against HIV-Associated Disseminated Histoplasmosis in the Americas: Unfolding the Different Stories of Four Centers , 2019, Journal of fungi.

[34]  A. Schwarzbold,et al.  Histoplasmosis, An Underdiagnosed Disease Affecting People Living With HIV/AIDS in Brazil: Results of a Multicenter Prospective Cohort Study Using Both Classical Mycology Tests and Histoplasma Urine Antigen Detection , 2019, Open forum infectious diseases.

[35]  Paula Capece,et al.  Histoplasmosis diseminada. Una infección oportunista en pacientes con infección por VIH. Experiencia en el Hospital Nacional Prof. A. Posadas, 2011-2017 , 2018 .

[36]  Mathieu Nacher,et al.  Burden of HIV-associated histoplasmosis compared with tuberculosis in Latin America: a modelling study. , 2018, The Lancet. Infectious diseases.

[37]  D. van Duin,et al.  Endemic Mycoses in Solid Organ Transplant Recipients. , 2018, Infectious disease clinics of North America.

[38]  T. Chiller,et al.  Multicenter Validation of Commercial Antigenuria Reagents To Diagnose Progressive Disseminated Histoplasmosis in People Living with HIV/AIDS in Two Latin American Countries , 2018, Journal of Clinical Microbiology.

[39]  A. Paniago,et al.  Clinical outcomes and risk factors for death from disseminated histoplasmosis in patients with AIDS who visited a high-complexity hospital in Campo Grande, MS, Brazil. , 2018, Revista da Sociedade Brasileira de Medicina Tropical.

[40]  T. Chiller,et al.  The important role of co-infections in patients with AIDS and progressive disseminated histoplasmosis (PDH): A cohort from Colombia , 2018, Medical mycology case reports.

[41]  W. Goldman,et al.  Genome Sequences Reveal Cryptic Speciation in the Human Pathogen Histoplasma capsulatum , 2017, mBio.

[42]  F. Queiroz-Telles,et al.  Neglected endemic mycoses. , 2017, The Lancet. Infectious diseases.

[43]  L. Goldani,et al.  Disseminated histoplasmosis and AIDS: a prospective and multicentre study to evaluate the performance of different diagnostic tests , 2017, Mycoses.

[44]  M. Brandt,et al.  Clinical and Laboratory Profile of Persons Living with Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome and Histoplasmosis from a Colombian Hospital. , 2016, The American journal of tropical medicine and hygiene.

[45]  L. Wheat,et al.  Histoplasmosis: Up-to-Date Evidence-Based Approach to Diagnosis and Management , 2015, Seminars in Respiratory and Critical Care Medicine.

[46]  Ángel González,et al.  Implementation of a Training Course Increased the Diagnosis of Histoplasmosis in Colombia. , 2015, The American journal of tropical medicine and hygiene.

[47]  G. Sarosi,et al.  Histoplasmosis Infections Worldwide: Thinking Outside of the Ohio River Valley , 2015, Current Tropical Medicine Reports.

[48]  Daniel Wagner Castro Lima Santos,et al.  Epidemiology of Invasive Fungal Infections in Patients with Acquired Immunodeficiency Syndrome at a Reference Hospital for Infectious Diseases in Brazil , 2014, Mycopathologia.

[49]  Mathieu Nacher,et al.  Fever in hospitalized HIV-infected patients in Western French Guiana: first think histoplasmosis , 2014, International journal of STD & AIDS.

[50]  M. Hanf,et al.  Tuberculosis and histoplasmosis among human immunodeficiency virus-infected patients: a comparative study. , 2014, The American journal of tropical medicine and hygiene.

[51]  J. Baddley,et al.  Histoplasmosis in Patients With Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS) , 2014, Medicine.

[52]  Beatriz L. Gómez,et al.  Histoplasmosis y sida: factores de riesgo clínicos y de laboratorio asociados al pronóstico de la enfermedad , 2012 .

[53]  Nina Singh,et al.  Donor‐Derived Fungal Infections in Organ Transplant Recipients: Guidelines of the American Society of Transplantation, Infectious Diseases Community of Practice † , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[54]  R. Cordeiro,et al.  Histoplasmosis in HIV-positive patients in Ceará, Brazil: clinical-laboratory aspects and in vitro antifungal susceptibility of Histoplasma capsulatum isolates. , 2012, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[55]  Clara Inés Agudelo,et al.  Histoplasmosis en Colombia: resultados de la encuesta nacional, 1992-2008 , 2011 .

[56]  T. Chiller,et al.  Development and Evaluation of an Enzyme-Linked Immunosorbent Assay To Detect Histoplasma capsulatum Antigenuria in Immunocompromised Patients , 2009, Clinical and Vaccine Immunology.

[57]  C. Kauffman Diagnosis of histoplasmosis in immunosuppressed patients , 2008, Current opinion in infectious diseases.

[58]  M. Silva-Vergara,et al.  Disseminated histoplasmosis in acquired immunodeficiency syndrome patients in Uberaba, MG, Brazil , 2008, Mycoses.

[59]  R. S. Mota,et al.  Clinical and laboratory features of disseminated histoplasmosis in HIV patients from Brazil , 2007, Tropical medicine & international health : TM & IH.

[60]  B. Wanke,et al.  Study of 30 cases of histoplasmosis observed in the Mato Grosso do Sul State, Brazil. , 2007, Revista do Instituto de Medicina Tropical de Sao Paulo.

[61]  J. A. S. Casotti,et al.  Disseminated histoplasmosis in HIV positive patients in Espírito Santo state, Brazil: a clinical-laboratory study of 12 cases (1999-2001). , 2006, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

[62]  E. De Francesco Daher,et al.  Risk factors for death in acquired immunodeficiency syndrome-associated disseminated histoplasmosis. , 2006, The American journal of tropical medicine and hygiene.

[63]  Á. Restrepo,et al.  Disseminated histoplasmosis: a comparative study between patients with acquired immunodeficiency syndrome and non-human immunodeficiency virus-infected individuals. , 2005, The American journal of tropical medicine and hygiene.

[64]  N. Sosa,et al.  Disseminated histoplasmosis in patients with AIDS in Panama: a review of 104 cases. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[65]  T. White,et al.  Phylogeography of the fungal pathogen Histoplasma capsulatum , 2003, Molecular ecology.

[66]  J. Knobloch,et al.  Evaluation of Two Nested PCR Assays for Detection of Histoplasma capsulatum DNA in Human Tissue , 2002, Journal of Clinical Microbiology.

[67]  K. Dietz,et al.  Comparison of staining methods and a nested PCR assay to detect Histoplasma capsulatum in tissue sections. , 2002, American journal of clinical pathology.

[68]  T. M. Daniel,et al.  Drama and discovery: the story of histoplasmosis. , 2002, Contributions in medical studies.

[69]  K. Shutt,et al.  Factors associated with severe manifestations of histoplasmosis in AIDS. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[70]  Bodensteiner Dc,et al.  Disseminated histoplasmosis in patients with AIDS. , 1992 .

[71]  J. Borleffs,et al.  [Histoplasma capsulatum infection, a manifestation of AIDS unusual for The Netherlands]. , 1990, Nederlandsch tijdschrift voor geneeskunde.

[72]  J. Loyd,et al.  Histoplasmosis in normal hosts. , 1981, Medicine.

[73]  J. Karbaat,et al.  Histoplasmosis in Dutch servicemen returning from Surinam. , 1967, Tropical and geographical medicine.

[74]  W. Whitehouse,et al.  ESTIMATES OF THE PREVALENCE OF TUBERCULOUS AND HISTOPLASMAL INFECTIONS IN A SAMPLE OF THE POPULATION OF TECUMSEH, MICHIGAN, 1960. , 1965, American Review of Respiratory Disease.

[75]  C. Walig [HISTOPLASMIN TESTING IN A GROUP OF DUTCH SOLDIERS RETURNING FROM SURINAM]. , 1965, Nederlands militair geneeskundig tijdschrift.

[76]  J. Wiersema A CASE OF HISTOPLASMOSIS IN SURINAM. , 1963, Tropical and geographical medicine.

[77]  G. Baum,et al.  The history of histoplasmosis, 1906 to 1956. , 1957, The New England journal of medicine.

[78]  A. Wildervanck,et al.  Two cases of histoplasmosis on farms near Paramaribo, Surinam; investigations into the epidemiology of the disease. , 1953, Documenta de medicina geographica et tropica.

[79]  A. Treurniet,et al.  Contributions to the geographical pathology of Surinam. First case of generalized histoplasmosis in Surinam. , 1952, Documenta de medicina geographica et tropica.

[80]  C. Dolea,et al.  World Health Organization , 1949, International Organization.

[81]  S. T. Darling THE MORPHOLOGY OF THE PARASITE (HISTOPLASMA CAPSULATUM) AND THE LESIONS OF HISTOPLASMOSIS, A FATAL DISEASE OF TROPICAL AMERICA , 1909, The Journal of experimental medicine.

[82]  S. T. Darling A PROTOZOÖN GENERAL INFECTION PRODUCING PSEUDOTUBERCLES IN THE LUNGS AND FOCAL NECROSES IN THE LIVER, SPLEEN AND LYMPHNODES. , 1906 .

[83]  R. Negroni,et al.  [Histoplasmosis in AIDS patients without tegumentary manifestations]. , 2018, Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia.

[84]  M. C. Cánepa,et al.  [Disseminated histoplasmosis. An oportunistic infection in HIV positive patients Experience in the Hospital Nacional Prof. A. Posadas, 2011-2017]. , 2018, Revista chilena de infectología.

[85]  T. Chiller,et al.  High Mortality and Coinfection in a Prospective Cohort of Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome Patients with Histoplasmosis in Guatemala. , 2017, The American journal of tropical medicine and hygiene.

[86]  C. Mejía,et al.  [Disseminated histoplasmosis and HIV infection: Case series in a Peruvian hospital]. , 2017, Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia.

[87]  J. A. de Araújo Filho,et al.  Disseminated histoplasmosis in AIDS patients: an urban disease. Experience in a metropolis in the middle east of Brasil. , 2017, Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive.

[88]  Disseminated histoplasmosis in Central and South America, the invisible elephant: the lethal blind spot of international health organizations. , 2016, AIDS.

[89]  G. Deepe 265 – Histoplasma capsulatum (Histoplasmosis) , 2015 .

[90]  E. Castañeda,et al.  Histoplasmosis: results of the Colombian national survey, 1992-2008. , 2011, Biomedica : revista del Instituto Nacional de Salud.

[91]  Y. Swica,et al.  Proposal for the inclusion of misoprostol in the WHO model list of essential medicines , 2009 .

[92]  M. Demar,et al.  Histoplasmosis and acquired immunodeficiency syndrome: a study of prognostic factors. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[93]  H. D. Riley The history of histoplasmosis. , 1983, The Journal of the Oklahoma State Medical Association.

[94]  Good Ra,et al.  Pathogenesis and clinical spectrum of histoplasmosis. , 1973 .

[95]  W. Collier,et al.  [Geographic pathology of Surinam. VI. Histoplasmosis in mammals of Surinam]. , 1952, Antonie van Leeuwenhoek.